Axa’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8M | Sell |
|
|||||
|
2025
Q1 | $40.4M | Buy |
|
|||||
|
2024
Q4 | $37.6M | Buy |
|
|||||
|
2024
Q3 | $39.5M | Sell |
|
|||||
|
2024
Q2 | $47.2M | Buy |
|
|||||
|
2024
Q1 | $35.3M | Buy |
|
|||||
|
2023
Q4 | $34.3M | Sell |
|
|||||
|
2023
Q3 | $32.1M | Sell |
|
|||||
|
2023
Q2 | $33.5M | Buy |
|
|||||
|
2023
Q1 | $37.4M | Sell |
|
|||||
|
2022
Q4 | $42.1M | Sell |
|
|||||
|
2022
Q3 | $48.5M | Sell |
|
|||||
|
2022
Q2 | $51.2M | Buy |
|
|||||
|
2022
Q1 | $33M | Sell |
|
|||||
|
2021
Q4 | $38.1M | Buy |
|
|||||
|
2021
Q3 | $30.9M | Buy |
|
|||||
|
2021
Q2 | $23.7M | Sell |
|
|||||
|
2021
Q1 | $24.5M | Sell |
|
|||||
|
2020
Q4 | $33M | Buy |
|
|||||
|
2020
Q3 | $27.8M | Sell |
|
|||||
|
2020
Q2 | $55M | Buy |
|
|||||
|
2020
Q1 | $26.1M | Sell |
|
|||||
|
2019
Q4 | $32.2M | Sell |
|
|||||
|
2019
Q3 | $26.1M | Buy |
|
|||||
|
2019
Q2 | $28.8M | Buy |
|
|||||
|
2019
Q1 | $29.5M | Sell |
|
|||||
|
2018
Q4 | $31.1M | Sell |
|
|||||
|
2018
Q3 | $35.4M | Sell |
|
|||||
|
2018
Q2 | $39.3M | Buy |
|
|||||
|
2018
Q1 | $30.8M | Sell |
|
|||||
|
2017
Q4 | $34.3M | Sell |
|
|||||
|
2017
Q3 | $35.8M | Sell |
|
|||||
|
2017
Q2 | $36.5M | Sell |
|
|||||
|
2017
Q1 | $36.3M | Sell |
|
|||||
|
2016
Q4 | $34.9M | Buy |
|
|||||
|
2016
Q3 | $36.5M | Sell |
|
|||||
|
2016
Q2 | $36.1M | Sell |
|
|||||
|
2016
Q1 | $38.8M | Buy |
|
|||||
|
2015
Q4 | $44.5M | Sell |
|
|||||
|
2015
Q3 | $48.7M | Sell |
|
|||||
|
2015
Q2 | $63.7M | Buy |
|
|||||
|
2015
Q1 | $57.8M | Buy |
|
|||||
|
2014
Q4 | $38.6M | Sell |
|
|||||
|
2014
Q3 | $31.3M | Buy |
|
|||||
|
2014
Q2 | $25.8M | Buy |
|
|||||
|
2014
Q1 | $27.3M | Buy |
|
|||||
|
2013
Q4 | $26M | Buy |
|
|||||
|
2013
Q3 | $14.4M | Buy |
|
|||||
|
2013
Q2 | $10.9M | Buy |
|